Live Breaking News & Updates on Rare Metabolic

Stay updated with breaking news from Rare metabolic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eiger To Discontinue Peginterferon Lambda Trial In CHD Patients; Stock Down In Premarket

Eiger BioPharmaceuticals, Inc. (EIGR), a commercial-stage biopharmaceutical company focused on rare metabolic diseases, Wednesday said it has decided to discontinue the Phase 3 LIMT-2 study of peginterferon lambda in patients with chronic hepatitis delta or CHD. ....

David Apelian , Eiger Biopharmaceuticals Inc , More Such Health News , Eiger Biopharmaceuticals , Data Safety Monitoring Board , Peginterferon Lambda , Iger Peginterferon Lambda , Iger To Discontinue , Hd Patient , Rare Metabolic ,

Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies. ....

David Apelian , Sylvia Wheeler , Aljanae Reynolds , Progeroid Laminopathies , Company Annual Report On Form , Prnewswire Eiger Biopharmaceuticals Inc , National Institutes Of Health , Eiger Biopharmaceuticals Inc , Anges Inc , Complete Randomization , Startup Activities , Cash Equivalents , Short Term Debt Securities , Based Regimens , Peginterferon Lambda , National Institutes , Processing Deficient Progeroid , Rare Metabolic , Pediatric Disease , Priority Review Voucher , Full Year , Distribution Agreement , Private Securities Litigation Reform Act , Quarterly Report , Annual Report , Consolidated Statements ,

Eiger BioPharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies. ....

Sylvia Wheeler , Progeroid Laminopathies , David Cory , Sarah Mathieson , Company Annual Report On Form , Prnewswire Eiger Biopharmaceuticals Inc , National Institutes Of Health , Eiger Biopharmaceuticals Inc , Corporate Affairs , Study Topline Data , Study Activating Sites , Hyperinsulinism Avant , Cash Position , Cash Equivalents , Based Regimens , Peginterferon Lambda , National Institutes , Processing Deficient Progeroid , Rare Metabolic , Pediatric Disease , Priority Review Voucher , Private Securities Litigation Reform Act , Quarterly Report , Annual Report , Consolidated Statements , Operations Financial ,

Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies. ....

Sylvia Wheeler , Lisa Kelly Croswell , Progeroid Laminopathies , David Cory , Sarah Mathieson , Company Annual , National Institutes Of Health , European Commission , Drug Administration , Prnewswire Eiger Biopharmaceuticals Inc , Eiger Biopharmaceuticals Inc , Anges Inc , Corporate Affairs , Active Dialogue , Potential Peginterferon Lambda , Study Topline Data Planned , Cash Position , Cash Equivalents , Newly Diagnosed Outpatient , Emergency Use Authorization , Delta Virus , Peginterferon Lambda , National Institutes , Hutchinson Gilford Progeria Syndrome , Processing Deficient Progeroid Laminopathies , Rare Metabolic ,

Missouri Man Convicted of Killing 9-Year-Old Special Needs Son After Calling 911, Claiming He Disappeared During a Carjacking

Dawan Ferguson was charged in 2019, 16 years after he claimed a carjacker took his vehicle with his 9-year-old son still inside. He was not found since. ....

United States , Christian Ferguson , Dawan Ferguson , Monica Ferguson , John Schlesinger , Found Inconsistencies Around Dawan , Louis County , Rare Metabolic , A911 Call , St Louis County ,